Showing results (601-610 of 726) with videos related to

Sort By:
Pageof 73
The Oncologist|December 8, 2020
Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or OxaliplatinRudolph M Navari, Kathryn J Ruddy, Thomas W LeBlanc, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2011
A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancerG R Blumenschein, F Kabbinavar, H Menon, et al.
Immunity|December 27, 2011
Early Th1 cell differentiation is marked by a Tfh cell-like transitionShingo Nakayamada, Yuka Kanno, Hayato Takahashi, et al.
Breast (Edinburgh, Scotland)|March 29, 2025
Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancerJoyce O'Shaughnessy, Sara M Tolaney, Denise A Yardley, et al.
Science (New York, N.Y.)|March 16, 2019
Redefining near-unity luminescence in quantum dots with photothermal threshold quantum yieldDavid A Hanifi, Noah D Bronstein, Brent A Koscher, et al.
Oncotarget|April 7, 2016
Analysis of tumor template from multiple compartments in a blood sample provides complementary access to peripheral tumor biomarkersWilliam M Strauss, Chris Carter, Jill Simmons, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 1997
Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancerC H Weaver, L S Schwartzberg, R Birch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2014
Type I IFN induces binding of STAT1 to Bcl6: divergent roles of STAT family transcription factors in the T follicular helper cell genetic programShingo Nakayamada, Amanda C Poholek, Kristina T Lu, et al.
Frontiers in Oncology|September 28, 2020
Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast CancerKatia Khoury, Antoinette R Tan, Andrew Elliott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorinLee S Schwartzberg, Istvan Petak, Clinton Stewart, et al.
Pageof 73